The NF-κB pathway, implicated in NPC and other diseases (e.g., inflammatory bowel disease, rheumatoid arthritis, lupus) [42], has a debated role in NPC tumorigenesis, with some studies suggesting it as a primary driver and others as part of a broader mutational landscape. The gene discussed is NFKB1; the disease is systemic lupus erythematosus.